The 2023 Citeline Awards winners by category:
- Best Patient-facing Technology Initiative: TrialWire
- Best Use of Artificial Intelligence in Clinical Trials: Yseop
- Best Sponsor-facing Technology Initiative: TransPerfect Life Sciences
- Champion of Diversity & Inclusion in Clinical Research – Sponsored by ICON: Sanofi
- Most Successful Early Phase Research (Preclinical & Phase I): Avidity Biosciences
- Clinical Research Team of the Year: George Clinical
- Clinical Trial Result of the Year: Tarsus Pharmaceuticals
- Excellence in Rare Disease Drug Development: Agios Pharmaceuticals
- Most Innovative Start-up Company: Electra Therapeutics
- Clinical Partnership of the Year: Medidata, a Dassault Systèmes Company, and Circuit Clinical
- Excellence in Patient Recruitment & Engagement: Javara
- Excellence in Use of Real-World Evidence: COTA
London, UK – 28th April 2023 – Citeline is proud to announce that the winners have been announced for the 2023 Citeline Awards. The Awards recognize excellence and innovation in the pharmaceutical industry, celebrating the companies and individuals who are driving progress in drug development.
Nearly 300 people attended the Awards ceremony which took place at the Westin Boston Seaport Hotel, Boston, MA, USA. The Citeline Awards span 12 categories, covering a spectrum of key R&D activities, from successes in early and late-stage research, to advances in technological tools, to innovations in trial design and patient recruitment.
Best Patient-facing Technology Initiative: TrialWire is the leading digital patient recruitment Platform that uses AI and algorithms to rapidly AI-Match patients with studies.
Best Use of Artificial Intelligence in Clinical Trials: Yseop is a French software company, specializing in no code intelligent report automation, using natural language generation.
Best Sponsor-facing Technology Initiative: TransPerfect Life Sciences provides a full suite of e-clinical, product development, language and technology solutions to clients.
Champion of Diversity & Inclusion in Clinical Research – Sponsored by ICON: Sanofi’s Diversity, Equity & Inclusion (DE&I) strategy is built around three key pillars: building representative leadership, creating a work environment where employees can bring their best selves and engaging with the company’s diverse communities.
Most Successful Early Phase Research (Preclinical & Phase I): Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies to address unmet medical need in a wide range of diseases.
Clinical Research Team of the Year: George Clinical is a contract research organization that engages some of the world’s most distinguished scientific expertise in chronic disease.
Clinical Trial Result of the Year: Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company that embodies the values of commitment, empowerment, and teamwork.
Excellence in Rare Disease Drug Development: Agios Pharmaceuticals Inc. is a bio pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias.
Most Innovative Start-up Company: Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Clinical Partnership of the Year: Medidata, a Dassault Systèmes company, and the exclusive partnership with Circuit Clinical, an Integrated Research Organization (IRO). With Medidata’s investment, Circuit Clinical expanded its Decentralized Clinical Trial (DCT) network to 500 physician investigators and 15M patients to help to bring clinical research as a care option to more people in need.
Excellence in Patient Recruitment & Engagement: Javara delivers clinical research as a care option through unity and trust by enabling the integration of research and clinical care services to improve health and change lives.
Excellence in Use of Real-World Evidence: Through the use of proprietary technology, advanced analytics and deep expertise to organize complex data, COTA provides a comprehensive picture of cancer that can be used to advance care and research.
Karen Currie, Executive Director, Clinical Intelligence, Citeline: “We’re thrilled to announce the Citeline Awards winners for 2023. This recognition is a testament to the hard work and dedication of all our entrants, who are passionate about advancing drug development and improving patient outcomes. A big thank you to our nominees, our headline sponsor ICON and judges who contributed to the 7th annual Citeline Awards!”
For more information about the Citeline Awards, please visit: https://pharmaintelligence.informa.com/citelineawards2023
Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyse data used to drive clinical, commercial and regulatory related decisions and create real-world opportunities for growth.
Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted health science partners, visit Citeline.